Buy & Sell Bitdeer Technologies Group (BTDR) – Bitdeer Technologies Group Price Today
Key Stats
- $4.17BMarket Cap
- TechnologySector
- -18.32%3M Drawdown
- $5.94BEnterprise Value
- -Dividend Yield
- 87% Buy | 13% SellTrading Activity
- 14 daysTypical Hold Time
Bitdeer Technologies Group (BTDR) is currently valued at a market capitalization of $4.17B, with an enterprise value of $5.94B. Over the past 52 weeks, Bitdeer Technologies Group has traded between a low of $7.28 and a high of $25.9, highlighting its annual price range. Over the past three months, Bitdeer Technologies Group has recorded a drawdown of -18.32%, reflecting recent price volatility. On average, investors hold Bitdeer Technologies Group for approximately 14 days, indicating typical investor behavior on the platform.
About Bitdeer Technologies Group
Bitdeer is a world-leading technology company for blockchain and high-performance computing. It provides comprehensive digital asset mining solutions, including cloud mining, hosting, and data center management.
Most Recent News
Supreme Court rules government geofence data collection is a Fourth Amendment search.
The U.S. Supreme Court ruled in Chatrie v. U.S. that government collection of location data via geofence warrants constitutes a search under the Fourth Amendment. This decision overturns a lower court ruling and requires further review of whether the...

KraneShares China Internet ETF trades near lows amid AI growth and geopolitical risks, rated HOLD.
The KraneShares CSI China Internet ETF (KWEB) provides focused exposure to leading Chinese internet and AI companies and is currently trading near its 52-week lows. The ETF benefits from strong AI-driven growth, government support, and attractive val...

DBV Technologies plans BLA submission for VIASKIN® Peanut patch in kids 4-7 after FDA collaboration.
DBV Technologies is preparing to submit a Biologics License Application (BLA) for its VIASKIN® Peanut patch aimed at children aged 4 to 7 years. The company has engaged in detailed discussions with the FDA to ensure a thorough and efficient review pr...
